Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Interpreting the Cancer Genome

Abstract PR09: Fine temporal and spatial dissection of medulloblastoma progression with MADM, a mouse genetic mosaic model

Brit Ventura, Maojin Yao, Ying Jiang, Kelsey Wahl, Fausto Rodriguez, Charles G. Eberhart and Hui Zong
Brit Ventura
1University of Virginia, Charlottesville, VA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maojin Yao
1University of Virginia, Charlottesville, VA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Jiang
1University of Virginia, Charlottesville, VA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelsey Wahl
2University of Oregon, Eugene, OR,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fausto Rodriguez
3Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles G. Eberhart
3Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Zong
1University of Virginia, Charlottesville, VA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.FBCR13-PR09 Published October 2013
  • Article
  • Info & Metrics
Loading

Abstract

Malignant cancers evolve over time with multiple contributing oncogenic mutations, and contain both tumor and niche cells. To understand when mutations contribute to malignant progression and how tumor and niche cell interact, we use a novel mouse genetic system termed MADM (Mosaic Analysis with Double Markers). MADM enables the tracking of tumorigenic cells from early stages with single cell resolution in vivo. Starting with a mouse heterozygous for a tumor suppressor gene (TSG), MADM can generate sporadic TSG-null cells via Cre-loxP mediated inter-chromosomal mitotic recombination events. Further, MADM unequivocally labels mutant cells with GFP, enabling lineage tracing of mutant cells with clear distinction from neighboring normal cells. Following cell division generating a mutant GFP+ cell, the sibling wildtype (WT) cell (RFP+) can also be assessed as an in situ internal control. We have applied MADM to model the Sonic Hedgehog (SHH)-subtype of medulloblastoma, the most common pediatric brain tumor.

In the developing cerebellum, unipotent granule neuron progenitors (GNPs) proliferate at the cerebellar surface in response to active Sonic hedgehog (SHH) signaling. Somatic mutation of the SHH receptor, Patched (Ptc), can lead to hyperactivation of the pathway, GNP overproliferation, and eventual malignancy. In addition to Ptc mutation, it has been reported that patients with medulloblastoma have a much worse prognosis when the tumor suppressor TRP53 (p53) is mutated. However, the timing of p53 contribution to tumorigenesis is still unclear. Here we used MADM to inactivate p53 in sporadic GNP cells in a Ptc heterozygous mouse model. To pinpoint the timing of p53 contribution to tumor progression, we performed a time course analysis of green-to-red cell number ratio (G/R ratio or mutant/wildtype). Our preliminary data suggest that the loss of p53 does not contribute to tumor progression until mid-stages of tumor progression since G/R ratio remains 1 in early lesions induced by the Ptc mutation.

For spatial organization of tumor and niche cells, we took advantage of the lineage tracing ability of MADM since all tumor cells should be green while neighboring normal cells should be non-labeled. Because the loss of heterzygousity is induced in unipotent GNPs, we expect the GFP+ tumor cells to maintain this identity. Surprisingly we find GFP+ cells in tumors consist of two cell types, GNPs and astrocytes, suggesting the trans-differentiation of some mutant GNPs into astrocytes. To confirm the human relevance of our findings, we performed double FISH-IF analysis of human patient samples for PTCH and our preliminary data indicated that GFAP+ astrocytes within tumors carried similar genomic aberrations to tumor GNPs, implicating the lineage relationship between these two cell types. Finally, in vitro co-culture experiment provided initial evidence that tumor GNP-derived astrocytes provide support to tumor GNPs, hinting at intricate cellular interactions in medulloblastoma.

In summary, our findings indicated that MADM provides great temporal and spatial resolution for cancer research. Our preliminary data suggest that tumor progression is not a linear process and distinct tumor suppressor genes act at different stages, and that tumor-niche interactions could be more complex than previously thought.

Citation Format: Brit Ventura, Maojin Yao, Ying Jiang, Kelsey Wahl, Fausto Rodriguez, Charles G. Eberhart, Hui Zong. Fine temporal and spatial dissection of medulloblastoma progression with MADM, a mouse genetic mosaic model. [abstract]. In: Proceedings of the Third AACR International Conference on Frontiers in Basic Cancer Research; Sep 18-22, 2013; National Harbor, MD. Philadelphia (PA): AACR; Cancer Res 2013;73(19 Suppl):Abstract nr PR09.

  • ©2013 American Association for Cancer Research.
Back to top
Cancer Research: 73 (19 Supplement)
October 2013
Volume 73, Issue 19 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract PR09: Fine temporal and spatial dissection of medulloblastoma progression with MADM, a mouse genetic mosaic model
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract PR09: Fine temporal and spatial dissection of medulloblastoma progression with MADM, a mouse genetic mosaic model
Brit Ventura, Maojin Yao, Ying Jiang, Kelsey Wahl, Fausto Rodriguez, Charles G. Eberhart and Hui Zong
Cancer Res October 1 2013 (73) (19 Supplement) PR09; DOI: 10.1158/1538-7445.FBCR13-PR09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract PR09: Fine temporal and spatial dissection of medulloblastoma progression with MADM, a mouse genetic mosaic model
Brit Ventura, Maojin Yao, Ying Jiang, Kelsey Wahl, Fausto Rodriguez, Charles G. Eberhart and Hui Zong
Cancer Res October 1 2013 (73) (19 Supplement) PR09; DOI: 10.1158/1538-7445.FBCR13-PR09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Interpreting the Cancer Genome

  • Abstract IA27: Cell fate determinants as regulators of cancer metastasis
  • Abstract IA29: Functional genomics, experimental models and cancer
  • Abstract IA28: Haploinsufficiency in cancer
Show more 3

Interpreting the Cancer Genome: Oral Presentations - Proffered Abstracts

  • Abstract PR07: Systematic genetic interaction maps reveal rewiring of the stress response network and resulting vulnerabilities in leukemia and multiple myeloma cells
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement